Nautilus Biotechnology

Nautilus Biotechnology is a publicly traded (NASDAQ: NAUT) life-sciences company developing a single-molecule protein analysis platform aimed at unlocking the proteome for basic biology, medicine, and drug discovery. Its Voyager platform pairs a novel single-molecule proteomics instrument with reagents and software to quantify and map proteoforms at scale. The company partners with academic and pharmaceutical researchers on applications spanning biomarker discovery and the drug-development process. Nautilus operates as a research-tools and instrument company; it publishes a corporate site, blog, resource library, and investor relations pages, but does not currently expose a public developer API, SDKs, or a developer portal. Surfaced as an a16z portfolio company and enriched from public sources.

Nautilus Biotechnology is profiled on the APIs.io network. Tagged areas include Company, Bio Healthcare, Proteomics, Life Sciences, and Biotechnology.

Nautilus Biotechnology’s developer surface includes engineering blog, support, and 5 more developer resources.

🌐 Visit website 📡 Source on GitHub

15.6/100 emerging ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5

0 APIs

CompanyBio HealthcareProteomicsLife SciencesBiotechnologySingle-Molecule ProteomicsDrug DiscoveryResearch Tools

Kin Score

Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5

Composite quality — 15.6/100 · emerging

Contract Quality 0.0 / 25

Developer Ergonomics 1.3 / 20

Commercial Clarity 4.2 / 20

Operational Transparency 0.7 / 13

Governance 0.0 / 12

Discoverability 6.8 / 10

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 15

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/nautilus-biotechnology: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Build 1

SDKs, sample code, and the tooling you integrate with

GitHubOrganization

GitHubOrganization

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Operate 1

Status, limits, changes, and where to get help

Support

Support

Commercial 2

Pricing, plans, and the legal terms of use

PrivacyPolicy

PrivacyPolicy

TermsOfService

TermsOfService

Company 2

The organization behind the API

Website

Website

Blog

Blog

Source (apis.yml)

aid: nautilus-biotechnology
name: Nautilus Biotechnology
description: 'Nautilus Biotechnology is a publicly traded (NASDAQ: NAUT) life-sciences company developing a single-molecule
  protein analysis platform aimed at unlocking the proteome for basic biology, medicine, and drug discovery. Its Voyager platform
  pairs a novel single-molecule proteomics instrument with reagents and software to quantify and map proteoforms at scale.
  The company partners with academic and pharmaceutical researchers on applications spanning biomarker discovery and the drug-development
  process. Nautilus operates as a research-tools and instrument company; it publishes a corporate site, blog, resource library,
  and investor relations pages, but does not currently expose a public developer API, SDKs, or a developer portal. Surfaced
  as an a16z portfolio company and enriched from public sources.'
url: https://raw.githubusercontent.com/api-evangelist/nautilus-biotechnology/refs/heads/main/apis.yml
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://www.nautilus.bio/wp-content/uploads/2023/11/Screenshot-2023-11-09-at-10.19.50-AM.png
x-type: company
x-source: vc-portfolio
x-backed-by:
- a16z
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-20'
tags:
- Company
- Bio Healthcare
- Proteomics
- Life Sciences
- Biotechnology
- Single-Molecule Proteomics
- Drug Discovery
- Research Tools
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://nautilus.bio
- type: Blog
  url: https://www.nautilus.bio/blog/
- type: Support
  url: https://www.nautilus.bio/contact/
- type: PrivacyPolicy
  url: https://www.nautilus.bio/privacy-policy/
- type: TermsOfService
  url: https://www.nautilus.bio/terms-of-use/
- type: GitHubOrganization
  url: https://github.com/nautilusbio
- type: DomainSecurity
  url: security/nautilus-biotechnology-domain-security.yml
x-enrichment:
  date: '2026-07-20'
  status: nochange
  artifacts_added: 0
  pass: local-v1